רוקחות-פרמקולוגיה

Patient Compliance with Antihypertensive Therapy Appears Longer for Those Taking Angiotensin II Antagonists

The consistently higher persistence associated with the use of angiotensin II antagonists may help improve the management of blood pressure in patients with hypertension.

 One of the most challenging problems in the care of patients with high blood pressure is patient noncompliance with antihypertensive therapy.

A large, retrospective study led by M. A. Marentette took a look at how well patient-compliance with antihypertensive therapy persists in routine clinical settings in Saskatchewan, Canada. The study retrospectively reviewed persistence of medication compliance among more than 46,000 patients managed by Saskatchewan Health from 1994 through 1998, who received at least one prescription for antihypertensive medication, but none in the 12 months prior to that prescription.

 The prescriptions were classified as either angiotensin II antagonists, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, calcium channel blockers, or diuretics. Persistence of patient compliance with antihypertensive therapy was divided into four intervals, 180, 360, 540, and 720 days.


0 תגובות

השאירו תגובה

רוצה להצטרף לדיון?
תרגישו חופשי לתרום!

כתיבת תגובה

מידע נוסף לעיונך

כתבות בנושאים דומים

© ‫ e-Med
 כל הזכויות שמורות

 

התכנים המוצגים באתר זה מיועדים לאנשי צוות רפואי בלבד

אם כבר נרשמת, יש להקליד את פרטי הזיהוי שלך
עדיין לא נרשמת? באפשרותך לבצע רישום כאן
להרשמה לאתר